Evaluation of Recombinant Vaccinia Virus—Measles Vaccines in Infant Rhesus Macaques with Preexisting Measles Antibody

This publication has 45 references indexed in Scilit:

• Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity
  Proceedings of the National Academy of Sciences, 1999
• Measles vaccination of infants in a well-vaccinated population
  The Pediatric Infectious Disease Journal, 1995
• Long-term survival after Edmonston-Zagreb measles vaccination in Guinea-Bissau: Increased female mortality rate
  The Journal of Pediatrics, 1993
• Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein
  The Lancet, 1991
• TRIAL OF HIGH-DOSE EDMONSTON-ZAGREB MEASLES VACCINE IN GUINEA-BISSAU: PROTECTIVE EFFICACY
  The Lancet, 1988
• Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein.
  Proceedings of the National Academy of Sciences, 1988
• Evaluation of the structural proteins of the hamster neurotropic strain of measles virus with monoclonal antibodies
  Journal of Neuroimmunology, 1986
• Role of virus strain dm conventional and enhanced measles plaque neutralization test
  Journal of Virological Methods, 1981
• Persistence of maternal antibody in infants beyond 12 months: Mechanism of measles vaccine failure
  The Journal of Pediatrics, 1977
• MEASLES AS AN INDEX OF IMMUNOLOGICAL FUNCTION
  The Lancet, 1968